| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |